New approaches for imaging in gene therapy

European Journal of Radiology

Volumn 34, Issue 3, 2000, Pages 156-165

  Wunderbaldinger, Patrick ^a   Bogdanov Jr, Alexei ^b   Weissleder, Ralph ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

DNA; Gene therapy; Molecular imaging; Vectors

Indexed keywords

DISEASES; DNA; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOLOGY; RADIOTHERAPY; TISSUE;

GENE THERAPY; MOLECULAR IMAGING; NUCLEAR IMAGING; OPTICAL IMAGING;

GENES;

GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; MARKER GENE; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMID; PRIORITY JOURNAL; REVIEW; TARGET CELL; TRANSGENE; ULTRASOUND;

EID: 0033858130     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(00)00196-0     Document Type: Article

References (89)

1. Blaese R., Anderson W. The ADA human gene therapy protocol. Human Gene. Ther. 1:1990;327-329.
2. Sokol D., Gewirtz A. Gene therapy: basic concepts and recent advances. Crit. Rev. Eukaryot. Gene Expr. 6:1996;29-57.
3. Roth J., Cristiano R. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst. 89:1997;21-39.
4. Dubowchik G., Walker M. Receptor-mediated and enzyme-dependent targeting of cytotoxic naticancer drugs. Pharmacol. Ther. 83:1999;67-123.
5. Stewart A.K., Sutherland D.R., Nanji S., Zhao Y., Lutzko C., Nayar R., Peck B., Ruedy C., McGarrity G., Tisdale J., Dube I.D. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant autologous long-term marrow cultures. Hum. Gene Ther. 10:1999;1953-1964.
6. Andreansky S.S., He B., Gillespie G.Y., Soroceanu L., Markert J., Chou J., Roizman B, Whitley R.J. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc. Natl. Acad. Sci. USA. 93:1996;11313-11318.
7. Bogdanov A., Simonova M., Weissleder R. Towards imaging of gene expression: the engineering of metal binding sites. Nat. Biotechnol. Short Rep. 8:1997;22.
8. Service R. New probes open windows on gene expression, and more. Science. 280:1998;1010-1011.
9. Thomas J.W., Thomjas J.W., Kuo M.D., Chawla M., Waugh J.M., Yuksel E., Wright K.C., Gerrity P.M., Shenaq S.M., Whigham C.J., Fisher R.G. Vascular gene therapy. Radiographics. 18:1998;1373-1394.
10. Weissleder R., Moore A., Mahmood U., Bhorade R., Benveniste H., Chiocca E.A., Bassilion J.P. In vivo MR imaging of transgene expression. Nat Med. 6(3):2000;351-355.
11. Weissleder R. Molecular imaging: exploring the next frontier (editorial). Radiology. 212:1999;609-614.
12. Voss S., Kruskal J. Gene therapy: a primer for radiologists. Radiographics. 18:1998;1343-1372.
13. Jain R. Textbook of Gene Therapy. 1st ed. 1998;Hogrefe & Huber Publishers, Basel, Switzerland.
14. Mockrin S. 1st ed Molecular Genetics and Gene Therapy of Cardiovascular Diseases. 1:1996;Dekker, New York, NY.
15. Robbins P. 1st ed Methods in Molecular Imaging, Gene Therapy Protocols. 1:1997;Humana, Totowa, NJ.
16. Lewin B., Siliciano P., Klotz M. Genes IV. 6th ed:1997;Oxford University Press, Oxford, UK.
17. Watson J., Weiner A.M., Hopkins N.H. Molecular Biology of the Gene. 1987;Addison-Wesley Longmann, Inc. Pearson Education, New York, NY.
18. Hyde S.C., Gill D.R., Higgins C.F., Treziese A.E.O., MacVinish L.J., Cutbert A.W., Ratcliff R., Evans M.J., Colledge W.H. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature. 362:1993;250-255.
19. Nolta J.A., Yu X.J., Bahner I., Kohn D.B. Retroviral mediated transfer of the human glucocerebrosidase gene into culture Gaucher bone marrow. J. Clin. Invest. 90:1992;342-348.
20. Stevenson M., Iversen P. Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)conjugates synthetic antisense oligodeoxyribonucleotides. J. Gen. Virol. 70:1989;2673-2682.
21. Rosenberg S.A., Aesbersold P., Cornetta K., Kasid A., Morgan R.A., Moen R., Karson E.M., Lotze M.T., Yang Y.G., Topalian S.L., Merino M.J., Culver K., Miller A.D., Blaese M., Anderson W.F. Gene tranfer into humans-immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified with retroviral gene transduction. New. Engl. J. Med. 323:1991;57-578.
22. Contag P.R., Olomu I.N., Stevenson D.K., Contag C.H. Bioluminescent indicators in living mammals. Nat. Med. 4:1998;245-247.
23. Kasof G.M., Smeyne R.J., Curran T., Morgan J.I. Developmental expression of Fos-lacZ in the brains of postnatal transgenic rats. Brain Res. Dev. Brain Res. 93:1996;191-197.
24. Bogdanov A., Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol. 16:1998;5-10.
25. Bednarski M.D., Lee J.W., Callstrom M.R., Li K.C. In vivo target-specific delivery of macromolecular agents with MR- guided focused ultrasound. Radiology. 204(1):1997;263-268.
26. Price R.J., Skyba D.M., Kaul S., Skalak T.C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation. 98(13):1998;1264-1267.
27. Gao X., Huang L. Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes. Nucleic Acids Res. 21:1993;2867-2872.
28. Brody S., Crystal R. Adenovirus mediated in vivo gene transfer. Ann. NY Acad. Sci. 176:1994;90-101.
29. Fraefel C., Song S., Lim F., Lang P., Yu L., Wang Y., Wild P., Geller A.I. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70(10):1996;7190-7197.
30. Jacoby D.R., Fraefel C., Breakefield X.O. Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genes. Gene Ther. 4(12):1997;1281-1283.
31. Reynolds P.N., Feng M., Curiel D.T. Chimeric viral vectors-the best of both worlds? Mol. Med. Today. 5(1):1999;25-31.
32. Robbins P.D., Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol. Ther. 80(1):1998;35-47.
33. Boris-Lawrie K., Temin H. The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann. NY Acad. Sci. 716:1994;59-70.
34. Goldspiel B., Green L., Calis K. Human gene therapy. Clin. Pharm. 12:1993;488-505.
35. Haeusler J., Szoka F.J. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4:1993;372-379.
36. McCabe E. Clinical applications of gene therapy: emerging opportunities and current limitations. Biochem. Med. Metab. Biol. 50:1993;241-253.
37. Ledley F. Non-viral gene therapy. Curr. Opin. Biotechnol. 5:1994;626-636.
38. Schreier H. The new frontier: gene and oligonucleotide therapy. Pharm. Acta Helv. 68:1994;145-159.
39. Mulligan R.C. The basic science of gene therapy. Science. 260(5110):1993;926-932.
40. Wu G., Wu C. Delivery systems for gene therapy. Biotherapy. 3:1991;87-95.
41. Curiel T.J., Cook D.R., Wang Y., Hahn B.H., Ghosh S.K., Harrison G.S. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphteria toxin A chain gene. Hum. Gene Ther. 4:1993;741-747.
42. Lai W.C., Bennett M. DNA vaccines. Crit. Rev. Immunol. 18(5):1998;449-484.
43. Muramatsu T., Nakamura A., Park H.M. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals (Review). Int. J. Mol. Med. 1(1):1998;55-62.
44. Chmura S.J., Chmura S.J., Advani S.J., Kufe D.W., Weichselbaum R.R. Strategies for enhancing viral-based gene therapy using ionizing radiation [in process citation]. Radiat. Oncol. Invest. 7(5):1999;261-269.
45. Lawrie A., Brisken A.F., Francis S.E., Tayler D.I., Chamberlain J., Crossman D.C., Cumberland D.C., Newman C.M. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation. 99(20):1999;2617-2620.
46. Kaneda Y., Morishita R., Dzau V. Prevention of restenosis by gene therapy. Ann. NY Acad. Sci. 811:1997;299-308.
47. Isner J.M., Walsh K., Symes J. et al. Clinical protocol: arterial gene transfer for therapeutic angiogenesis in patients with peripherial artery disease. Hum. Gene Ther. 7:1996;959-988.
48. Tahlil O., Brami M., Feldman L.J., Branellec D., Steg P.G. The dispatch catheter as a delivery tool for arterial gene transfer. Cardiovasc. Res. 33:1997;181-187.
49. Kim H., Kim H., Greenleaf J.F., Kinnick R.R., Bronk J.T., Bolander M.E. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther. 7:1996;1339-1346.
50. Unger E.C., McCreery T.P., Sweitzer R.H. Ultrasound enhances gene expression of liposomal transfection. Invest. Radiol. 32(12):1997;723-727.
51. Bilbao G., Feng M., Rancourt C., Jackson W.H. Jr., Curiel D.T. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. FASEB. J. 11(8):1997;624-634.
52. Fraefel C., Jacoby D.R., Lage C., Hilderbrand H., Chou J.Y., Alt F.W., Breakefield X.O., Majzoub J.A. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 3(12):1997;813-825.
53. Bilbao G., Gomez-Navarro J., Curiel D.T. Targeted adenoviral vectors for cancer gene therapy. Adv. Exp. Med. Biol. 451:1998;365-374.
54. Johnston K.M., Jacoby D., Pechan P.A., Fraefel C., Borghesani P., Schuback D., Dunn R.J., Smith F.I., Breakfield X.O. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8(3):1997;359-370.
55. Aboody-Guterman K.S., Pechan P.A., Rainov N.G, Sena-Esteves M., Jacobs A., Snyder E.Y., Wild P., Schraner E., Tobler K., Breakefield X.O., Fraefel C. Green fluorescent protein as a reporter for retrovirus and helper virus- free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. Neuroreport. 8(17):1997;3801-3808.
56. Schellingerhout D., Bogdanov A., Marecos E., Spear M., Breakefield X.O., Weissleder R. Mapping the in vivo distribution of herpes simplex virions. Human. Gene. Therapy. 9:1998;1543-1549.
57. 99mTc-labeled adenovirus knob (serotype 5). Gene Ther. 5(6):1998;798-808.
58. De Marco G., Bogdanov A., Marecos E., Moore A., Simonova M., Weissleder R. MR imaging of gene delivery to the central nervous system with an artificial vector. Radiology. 208:1998;65-71.
59. Bogdanov A, Kayne L, Weissleder R. Graft copolymers as carriers for systemic delivery of expression vectors. In: Proceedings of the International Symposium for Controlled Release Bioactive Materials, Las Vegas, NV, 1998.
60. Bogdanov A, et al. Non-invasive imaging of gene delivery and biodistribution using novel DNA binding chelate. In: NASA-NCI Workshop on Sensors for Bio-Molecular Signatures. Pasadena, CA, 1999.
61. Weissleder R., Cheng H.C., Bogdanova A., Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imaging. 7:1997;258-263.
62. Moore A., Basilion J., Chiocca A., Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochem. Biophys. Acta. 1402:1998;239-249.
63. Moats R.A., Fraser S.E., Meade T.J. A 'smart' magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem. Int. Ed. 36:1997;726-731.
64. Tung CH, Bredow S, Mahmood U, Weissleder R. et al. A cathepsin D sensitive near infrared fluorescence probe for in vivo imaging of enzyme activity. Bioconj Chem 1999; 10(5): 892-6.
65. Iwashina T., Tovell D.R., Xu L., Tyrrell D.L., Knaus E.E., Wiebe L.I. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis. Drug Des. Deliv. 3:1988;309-321.
66. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., Safer M., Beattie B., Diresta G., Daghighian F., Augsensen F., Koutcher J., Zweit J., Humm J., Larson S.M., Finn R., Blasberg R. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58(19):1998;4333-4341.
67. Haberkorn U., Oberdorfer F., Gebert J. et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J. Nucl. Med. 37:1996;87-94.
68. Gambhir S.S., Barrio J.R., Phelps M.E., Iyer M., Namavari M., Satyamurthy N., Wu L., Green L.A., Bauer E., MacLaren D.C., Nguyen K., Berk A.J., Cherry S.R., Herschman H.R. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography [in process citation]. Proc. Natl. Acad. Sci. USA. 96(5):1999;2333-2338.
69. Glorioso J., DeLuca N., Fink D. Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49:1995;675-710.
70. Glorioso J. Gene therapy 1995: developments on the horizon (editorial). Gene Ther. 2:1995;81-83.
71. Freeman S.M., Whartenby K.A., Freeman J.L., Abboud C.N., Marrogi A.J. In situ use of suicide genes for cancer therapy. Semin. Oncol. 12:1996;488-512.
72. Huber B.E., Austin E.A., Richards C.A., Davis S.T., Good S.S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deanimase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deanimase. Proc. Natl. Acad. Sci. USA. 91:1994;8302-8306.
73. Ramesh R., Marrogi A.J., Munshi A., Abboud C.N., Freeman S.M. In vivo analysis of the bystander effect: a cytokine cascade. Exp. Hematol. 24:1996;829-838.
74. Bogdanov A., Simonova M., Weissleder R. Design of metal-binding green fluorescent protein variants. Biochim. Biophys. Acta. 1397:1998;56-64.
75. Simonova M., Weissleder R., Sergeyev N., Vilissova N., Bogdanov A. Jr. Targeting of green fluorescent protein expression to the cell surface. Biochem. Biophys. Res. Commun. 262(3):1999;638-642.
76. Johnson G.A., Benveniste H., Black R.D., Hedlund L.W., Maronpot R.R., Smith B.R. Histology by magnetic resonance microscopy. Magn. Reson. Q. 9(1):1993;1-30.
77. Smith B.R., Johnson G.A., Groman E.V., Linney E.A. Magnetic resonance microscopy of mouse embryos. Proc. Natl. Acad. Sci. USA. 91:1994;3530-3533.
78. Weissleder R., Reimer P., Lee A.S., Wittenberg J., Brady T.J. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. Am. J. Roentenol. 155:1990;1161-1167.
79. Shen T.T., Bogdanov A., Bogdanova A., Poss K., Brady T.J., Weissleder R. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Bioconjug. Chem. 7:1996;311-316.
80. Enochs W.S, Petherick P., Bogdanova A., Mohr U., Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology. 204:1997;417-423.
81. Okazaki M., Kuwata K., Miki Y., Shiga S., Shiga T. Electron spin relaxation of synthetic melanin and melanin-containing human tissue as studied by electron spin echo and electron spin resonance. Arch. Biochem. Biophy. 242:1985;197-205.
82. Isiklar I., Leeds N.E., Fuller G.N., Kumar A.J. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Am. J. Roentenol. 165(6):1995;1503-1512.
83. Stegman L.D., Rehemtulla A., Beattie B., Kievit E., Lawrence T.S., Blasberg R.G., Tjuvajev J.G., Ross B.D. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA. 96:1999;9821-9826.
84. Tjuvajev J.G., Finn R., Watanabe K., Joshi R., Oku T., Kennedy J., Beattie B., Koutcher J., Larson S., Blasberg R.G. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a pothential method for monitoring clinical gene therapy. Cancer Res. 56:1996;4087-4095.
85. Weissleder R., Simonova M., Bogdanova A., Bredow S., Enochs W.S., Bogdanov A. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 204:1997;425-429.
86. Fukumura D., Xavier R.T., Sugiura et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 94:1998;715-725.
87. Rogers B.E., Rosenfeld M.E., Khazaeli M.B., Mikheeva G., Stackhouse M.A., Liu T., Curiel D.T., Buchsbaum D.J. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J. Nucl. Med. 38:1997;1221-1229.
88. Zinn KR, Buchsbaum DJ, Mountz JM, Curiel DT, Chaudhuri TR, Kirkman R, Rogers BE. Application of type 2 human somatostatin receptor (hSSTr2) as a reporter for imaging gene transfer. In: Sixth International Conference of Anticancer Research. Kallithea, Halkidiki, Greece, 1998.
89. Mandell R.B., Mandell L.Z., Link Jr C.J. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59(3):1999;661-668.